IN VIVO: Deals Shaping The Medical Industry, May 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

Grifols SA (hemotherapy, diagnostics, and hospital IV drugs) is acquiring a 60% stake in privately held diagnostics company Progenika Biopharma SA for €37mm ($48mm), half of which was paid in cash and the rest in 885k nonvoting Class B Grifols shares (which are traded on the Spanish Mercado Continuo and Nasdaq). (Mar.)

Grifols and Progenika’s selling shareholders each have three-year call and put options regarding the acquisition of an additional 35% of...

More from Deal-Making

More from In Vivo